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Lymphocyticgastritis(LG)isassociatedwithhelicobacter pylori(Hp)andceliacdisease(CD).Weaimedtoclarifytherelationship
between Hp infection and CD by deﬁning a unique histopathology proﬁle of LG in these two diseases. Forty patients who under-
went upper endoscopy were divided into four groups: eight controls, ten active CD patients without Hp, twelve CD negative with
Hp, and ten active CD with Hp infection. Antral samples were assessed by immunohistochemical staining for CD20, CD3, CD4,
CD8, CD57, CNA42, and Ki67 for lymphoid aggregates, intraepithelial lymphocytes (IELs) number, density of lamina propria
(LP) lymphocytes, and inﬂammatory glandular involvement. Only IELs positive for CD3 and CD8 were increased signiﬁcantly in
CD patients with or without Hp infection. Hp did not contribute to the number of CD8 IELs. In complicated cases with Hp and
suspicious for CD, the number of CD8+ IELs hints toward a CD rather than Hp infection.
Copyright © 2007 Efrat Broide et al. This is an open access article distributed under the Creative Commons Attribution License,
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
1. INTRODUCTION
Helicobacter pylori (Hp) infection may cause several clin-
ical manifestations, ranging from asymptomatic to signiﬁ-
cant gastroduodenal disease including ulcer, bleeding, perfo-
ration, and adenocarcinoma [1]. No pathogenic mechanism
is known to explain the above diversity.
Celiac disease (CD) is a T-cell-mediated disorder of the
small bowel triggered by gluten in susceptible subjects. The
damageisnotconﬁnedonlytothesmallbowelbutmayaﬀect
the gastric mucosal structure and function [2]. In both con-
ditions, Hp and CD, a systemic humoral immune response
is detected, but much interest has been focused on the local
immune inﬂammatory reaction.
Lymphocytic gastritis (LG) was initially characterized by
Haot et al. in 1986 [3, 4]. It is deﬁned by the presence of
> 25 intraepithelial lymphocytes (IELs) (surface and upper
foveolar epithelium) per 100 epithelial cells, without taking
into account the mononuclear inﬂammatory cell inﬁltration
of the LP. This condition may be recognized endoscopically
as varioliform gastritis, nodularity, hypertrophic gastropa-
thy, and aphtous erosions [5, 6]. A similar histological en-
tity has been reported in association with a variety of gastric
infections,inﬂammatorydiseases,andinautoimmunedisor-
ders aﬀecting the gastric mucosa including CD, in adults [7–
9], as well as in pediatric patients [10–12]. Additionally, Hp
is a major etiology for LG, extensively documented in adults
[13,14]andchildren[15,16].Furthermore,investigationsof
the relationship between Hp infection and CD have yielded
conﬂicting results [9, 17], probably because of the diﬀerent
prevalence of Hp in the populations studied. Others have fo-
cused on the Hp-related LG in CD [6, 8] and recently on the
link between anemia, Hp, and CD [18]. The pathogenetic re-
lationshipbetweenCD,HpandLGisevenmorecomplicated
since gastric Hp existence attenuates duodenal lesions in CD
patients [19].
It is generally accepted that the major cytokine response
to Hp and CD has a T-helper 1 (Th1)-type proﬁle [20]. The
exact nature of the cellular response contributing to this in-
ﬂammatory proﬁle has not been determined, and less so in2 Mediators of Inﬂammation
Table 1: Demographic data.
Group Mean age ± SD yrs (range) Male/female Total no.
Controls 12.5 ±5.63 [3–18] 2/6 8
CD+/Hp- 9.85 ±10.78 [1.5–38] 1/9 10
CD-/Hp+ 15.66 ±5.08 [8–28] 3/9 12
CD+/Hp+ 10.9 ±3.93 [5–17] 2/8 10
P value NS NS
children.Conﬂictingresultsexistintheliteratureonthelym-
phocytic subpopulations, quantity and quality, inﬁltrating
the gastric mucosa in CD and Hp.
AsLGisamorphologicendpointofnumerousetiologies,
the literature is ripe with controversy [9] and since extensive
characterization of the lymphocytic populations inﬁltrating
thegastricmucosainCDandHpinfectedchildrenislacking,
the present study was undertaken. The aims were to look for
additional quantitative and qualitative histological features,
to deﬁne the immunophenotype of the gastric mucosa of the
two most prevalent etiologies of pediatric LG (CD and Hp
infection). Our secondary aim was to demonstrate a unique
histopathology proﬁle of LG by immunohistocemistry stain-
ing, trying to clarify the interrelationship between Hp and
CD in the pediatric population, thus shedding new light on
the two entity’s enigma.
2. PATIENTS AND METHODS
2.1. Patients
Forty patients referred for endoscopy due to upper gastroin-
testinalsymptoms(mostlyrecurrentabdominalpain,oriron
deﬁciency anemia) were included in the study. Patients were
divided into 4 groups group1 is eight normal controls (with-
out CD nor Hp infection); group 2 is ten patients with new
activeCDwithoutHpinfection;group3istwelveCeliacneg-
ative patients infected by Hp; and group 4 is ten new active
CD patients infected by Hp (Table 1). None of these patients
had any other gastrointestinal underlying disease including
evidence for food allergy, giardiasis, or inﬂammatory bowel
disease. The diagnosis of CD was based on the accepted his-
tological ﬁndings [9] supported by positive serology for CD
(antiendomysial and antitissue transglutaminase antibodies)
[10]. All CD patients were under normal gluten containing
diet at the time of diagnosis. Hp status was assessed accord-
ing to conventional biopsy-based criteria plus positive urease
test. All patients underwent esophago-gastro-duodenoscopy
using GIF-xp 20 endoscope; Pentax, Tokyo, Japan. At least 6
biopsies were obtained: 3 from the second part of the duo-
denum for diagnosing or exclusion of CD, and 3 from the
antrum; one for quick urease test and two for histologic ex-
amination. The local ethical committee approved the study.
2.2. Histopathologicalstudies
Sections obtained from gastric biopsies were immediately
ﬁxedinbuﬀeredformalinandembeddedonedgeinparaﬃn.
Serial 3µm thick sections were obtained for histological and
Table 2: Antibodies used for immunohistochemical evaluation.
Ab Source Clone no Ag retrieval Dilution
CD3 DAKO Polyclonal Citrate buﬀer 1:50
CD20 DAKO L26 Citrate buﬀer 1:400
CD4 Zymed ZT-17 Citrate buﬀer None
CD8 DAKO C8/144B Citrate buﬀer 1:40
CD57 Novocastra NK-1 Citrate buﬀer 1:50
Ki67 DAKO MIB-1 Citrate buﬀer 1:200
CNA42 DAKO CNA42 Citrate buﬀer 1:75
immunohistochemical examinations. Sections were stained
with hematoxylin-eosin and with Giemsa. The diagnosis of
LG was established if 25 lymphocytes per 100 gastric epithe-
lial cells inﬁltrated the surface epithelium. Furthermore, we
estimated the extent to which the inﬂammatory inﬁltrate in-
volved the LP and the mucosal glands. In addition, the num-
ber of mucosal and submucosal lymphoid aggregates were
counted. To clarify the nature of these inﬂammatory cells,
additional paraﬃn sections were immunostained with sev-
eral antibodies.
2.3. Immunohistochemicalstudies
Immunohistochemistry was performed using standard
methods. Threeµm sections were prepared from formalin-
ﬁxed, paraﬃn-embedded tissue blocks, air dried, and sub-
jected to deparaﬃnization with xylene and absolute alco-
hol. The immunoperoxidase stains were performed using a
panel of antibodies that included CD20, CD3, CD4, CD8,
CD57, CNA42, and Ki67 (Table 2), with appropriate dilu-
tions as recommended by the manufactures, using the Ven-
tana ES autoimmunostainer and the iVIEWDAB detection
kit from Ventana. The sections were counterstained with
Mayer’s hematoxylin.
2.4. Inﬂammationgrading
The gastric IELs were counted on the hematoxylin-eosin
stains per 100 consecutive gastric surface mucosal cells with
a X400 magniﬁcation (objectiveX10).
Thedensityofsubepitheliallymphocyteswasdetermined
semiquantitatively using a 4 tier grading system, according
to the percentage of the area in the LP inﬁltrated by the
inﬂammatory cells. Grade 0 is if less than 5% of the area
was inﬁltrated by inﬂammatory cells, grade 1 is between 5–
30%, grade 2 is between 30–60%, and grade 3 is if >60% of
the area was inﬁltrated. In order to evaluate the inﬂamma-
tory glandular involvement, glands containing inﬂammatory
cells were counted out of a ﬁxed total number of superﬁcial
glands; calculated as the percent of involved glands.
2.5. Statisticalanalysis
The data were analyzed using BMDP [11]. Continuous vari-
a b l e sw e r ec o m p a r e da c r o s sgr o u p su s i n ga n a l y s i so fv a ri a n c e
(ANOVA) withBonferroni’s correctionformultiple compar-
isons. Discrete (semi quantitative) variables were comparedEfrat Broide et al. 3
using Kruskal-Wallis nonparametric one-way analysis of
variance, with multiple comparisons. A p-value less or equal
than 0.05 was considered signiﬁcant.
3. RESULTS
Demographic data of the four examined groups of patients
are summarized in Table 1. The mean age of all groups and
gender’s ratio were not statistically signiﬁcant diﬀerent. In
CD as well as in Hp gastritis patients, increased numbers
of IEL compatible with the diagnosis of LG (45.5 ± 18.5p e r
100 gastric epithelial cells) compared to patients without LG
(10.8 ±4.5 per 100 gastric epithelial cells), were observed.
The highest proportion of LG (50%) was found in CD
patients without Hp infection, followed by patients with
CD infected by Hp (20%), Hp positive patients without CD
(8.3%) and none in the control group.
3.1. Lymphoidaggregates
The distribution and total number of lymphoid aggregates
in the antrum among the four diﬀerent groups are shown in
Table 3. Patients infected with Hp had the highest number of
lymphoid aggregates irrespective of the CD status. Three CD
patients with Hp and nine Hp infected patients without CD
had more than 2 lymphoid aggregates.
3.2. Immunohistochemicalresults
The mean number of Intraepithelial lymphocytes (IELs)
positive for CD3 was increased signiﬁcantly in CD pa-
tients with or without Hp infection compared to con-
trols [p ≤ 0.01, p ≤ 0.05 respectively], (Table 4). Similarly
the mean number of CD8+ IELs was increased signiﬁcantly
in CD patients with or without Hp infection compared to
controls (p<0.05) (Figure 1). Hp infection did not con-
tribute to the number of CD8+ IELs. In the Hp infected
group without CD, the number of CD8+ IELs was not signif-
icantly diﬀerent from the normal controls [Table 4]. A slight
increase in CD8+ lymphocytes was noted in the LP and intra
mucosal glands in the CD group patients compared with all
the other groups, although these results did not reach statis-
tical signiﬁcance.
CD4+ lymphocytes were slightly increased in the LP and
in the mucosal glands of the Hp+ patients compared with
controls and CD cases.
No statistical signiﬁcant diﬀerences were found for the
number and distribution of B lymphocytes (CD20+), Natu-
ral killer (NK) lymphocytes (CD57) and follicular dendritic
cells (CNA42) within all diﬀerent examined compartments
(IELs, LP and glands). The proliferation marker Ki67 did not
contribute to the results.
4. DISCUSSION
In order to investigate the diﬀerential contribution of Hp
infection to LG in an inﬂammatory condition like CD, the
gastric tissue inﬂammatory subpopulation proﬁle was inves-
tigated, by immunohistochemistry, and compared between
the 4 groups of patients. Past studies focused mainly on the
surface epithelial inﬁltrate as well as on the superﬁcial pit
gastric epithelium invasion by lymphocytes, and to a lesser
extent on the inﬁltrate in the LP and in the gastric glands.
The main ﬁnding of the present study was the highest
prevalence LG in pediatric CD+Hp− followed by CD−Hp+.
Forty ﬁve percent of CD patients are estimated to have
LG like in our study [8, 12]. However, LG appears to be sim-
ilarly frequent in Hp positive children with and without CD
[13]. Previous studies demonstrated that LG was found to be
more common in Hp positive children without CD than in
Hp negative children without CD. The IELs were almost ex-
clusively T cells [14]. There are still controversial results on
the contribution of CD and Hp infection to LG. Moreover,
the association between these pathologies to LG is not well
established [13–15]. Lymphocytic gastritis was reported in
36–45% of children with CD [6, 10, 13], and disappears af-
ter a gluten free diet. Hp infection is less frequently found in
patients with LG [13%] than with the usual chronic antral
gastritis [65–90%] [13]. CD is considered to be a population
at greatest risk for LG compared to Hp aﬀected patients.
Our study conﬁrmed the published results of an in-
creasednumberofIELsinbothCDandHpinfectedpatients.
The most prominent LG was found in CD patients without
Hp infection. Surprisingly, CD patients with associated Hp
infection showed a lower rate of LG. This evidence might be
explainedbythewellknownlimitedrollofbacterialinfection
in cytotoxicity. Hp convergent the immune response towards
Th2 response and suppress the Th1 immune response.
Previous investigators have published several sets of data
concerning the composition of the lymphocytic inﬁltrates in
thediﬀerentdiseases[16–20].DrutetalfoundthatLGinpe-
diatric CD patients contains a peculiar CD3, CD7 and CD8
intraepithelial lymphocyte population, that is not associated
with the presence of CD4, CD20, CD56 and CD57 IELs [21].
In Hp gastritis there is an increased number of mononu-
clear cells in the gastric LP, including B and T lymphocytes,
plasma cells, macrophages and mast cells. Lymphoid aggre-
gates are particularly characteristic of Hp infection [22]. It
hasbeenshownthatHpstimulatesBlymphocytesandcauses
an increase in their numbers predominantly in the LP [23].
Although immunity against Hp infection appears not to be
dependent on B cells, the role of T cells still remains to be
clariﬁed [24]. It appears however that the B cell proliferation
might be driven by activated lymphocytes (CD4+ cells) that
might recall and activate mononuclear phagocytes.
Bedoya et al. demonstrated that the cellular response in-
cludes an innate nonspeciﬁc response represented mainly by
po l ym o rp h o n u c l e a rc ell sa n dm ac r o p h a g e s ,a sw ella saTc ell
response with abundant positive staining with anti-CD8 an-
tibodies, was observed indicative of a predominance of sup-
pressor/cytotoxic T lymphocytes both in the LP and in the
epithelium [22].
Similarly we also showed the presence of CD3+ IELs
in both diseases (CD; Hp infection). Despite a potential
additive eﬀect between these two pathological processes,
it is impossible to diﬀerentiate between them, based only
on the number of the CD3+ IELs in the antral mucosa.
CD3 staining is a pan T lymphocyte marker and does4 Mediators of Inﬂammation
Table 3: Lymphoid aggregates in antrum.
Signiﬁcance between groups
Group 1
controls
Group 2
CD+/Hp-
Group 3
CD-/Hp+
Group 4
CD+/Hp+ [1-2] P[1–3] P[1–4] P[2-3] P[2–4] P[3-4]
Mean no. 0.125 0.900 3.75 2
SD 0.354 0.738 2.417 1.764 NS < 0.01 NS < 0.05 NS NS
Minimum 0 0 0 0
Maximum 1 2 7 5
(a) (b) (c) (d)
(e) (f) (g) (h)
(i) (j) (k) (l)
Figure 1: Immunohistochemical staining for CD3, CD4, and CD8 in the four diﬀerent groups. Controls: (a)-CD3, (b)-CD4, (c)-CD8 (all
o.mX200); Hp+/CD-: (d)-CD3 (o.mX400), (e)-CD4 (o.mX200), (f)-CD8 (o.mX200); Hp-/CD+: (g)-CD3 (o.mX200), (h)-CD4 (o.mX400),
(i)-CD8 (o.mX400); Hp+/CD+: (j)-CD3, (k)-CD4, (l)-CD8 (all o.mX200).
not diﬀerentiate between CD4 helper and CD8 suppres-
sor/cytotoxic cells, therefore we aimed to characterize the T
cell subsets immunophenotype (CD4+, CD8+, CD57).
In our study the CD8+ IELs were signiﬁcantly higher in
CD patients (20/100 epithelial cells), compared to controls
(1/100 epithelial cells) or Hp infected patients without CD
(2/100 epithelial cells). We assume that in undiagnosed pa-
tients with histological features compatible with LG, higher
counts of CD8+ IELs may imply that the diagnosis is CD
rather than Hp gastritis. Our ﬁndings support the published
data that CD8+/CD4− IELs are involved signiﬁcantly in the
pathogenesis of CD [25].
Inourstudy,thelowexpressionofCD57inthelymphoid
cells, both in the epithelium, in the LP as well as in the mu-
cosal glands indicate that NK cells may play a negligible role
in these two pathologies.
We also tried to diﬀerentiate between these two causative
agents of LG by looking at the proliferation marker, Ki67. Al-
though both conditions were associated with a prominent
adaptive immune activity, no increase in the proliferation
index of the surface epithelium was demonstrated in these
pathologies.
Dendritic cells (CNA42+) which serve as professional
antigen presenting cells did not show an increased expres-
sion in both pathologies. This may indicate that the process
of antigen presentation occurred in the lymph nodes. This
notion is supported by the absence of CD4 (T helper) cells
in the immune cell inﬁltrates found in the aﬀected tissues.Efrat Broide et al. 5
Table 4: Mean intraepithelial lymphocytes number (immunohistochemistry staining).
Signiﬁcance between groups
Imunohistochemical
staining
Group 1
controls
Group 2
CD+/Hp-
Group 3
CD-/Hp+
Group 4
CD+/Hp+ [1-2] P[1–3] P[1–4] P[2-3] P[2–4] P[3-4]
CD3 [mean ± SD] 1 16 ±7.23 .2 ±2.21 4 ±4.1 < 0.05 NS < 0.01 NS NS < 0.05
CD8 0 20.2±10.12 .2 ±2.11 6 .8 ±8.8 < 0.05 NS < 0.05 < 0.05 NS < 0.05
Ki67 0 2.8 ±2.30 2 ±1.6 N SN SN SN SN SN S
Thus, in the infected area we observed mainly the eﬀector
CD8 lymphocytes.
In addition to all the above, we conﬁrmed the published
results that the highest number of lymphoid follicles was ob-
served in a similar proportion of children with or without
CD, who were Hp positive independent of the presence of
LG.
The inﬂammatory inﬁltrate in the LP and in the mu-
cosal glands does not contribute to the diﬀerentiation be-
tween these diseases.
Insummary,ourstudyaimedtoexplorethecontribution
of CD and Hp infection to LG and to characterize the dif-
ferent immunoproﬁles of the gastric inﬂammatory cells in-
volved in these diseases. We were looking for an applicable
histological tool that might diﬀerentiate between cases of CD
and Hp infection with overlapping clinical and histological
features.
We suggest that in very young patients infected by Hp
and suspicion for having atypical CD (negative serology with
increasedIELswithnormalvillousarchitecture-MarshIclas-
siﬁcation) with a debatable diagnosis of CD versus Hp infec-
tion, the number of CD8+ IELs in the antrum might hint
toward the diagnosis of CD rather than Hp infection, and
the number of lymphoid follicles directs toward the diagno-
sisofHpinfection.Thus,itisimportanttoincludeimmuno-
histochemical analysis of CD8 lymphocytes in the antrum in
undeﬁned cases of CD.
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